A Response to Letter to the Editor: Can Imeglimin Improve the Systolic Time Intervals in Diabetes Mellitus?

Diabetes Ther. 2023 Jun;14(6):1075-1076. doi: 10.1007/s13300-023-01409-1. Epub 2023 May 12.

Authors

Taisuke Uchida¹, Hiroaki Ueno², Ayaka Konagata¹, Norifumi Taniguchi¹, Fumiko Kogo¹, Yuma Nagatomo¹, Koichiro Shimizu¹, Hideki Yamaguchi¹, Kazuya Shimoda¹

Affiliations

¹ Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
² Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan. intron@med.miyazaki-u.ac.jp.

No abstract available

Keywords: Ankle–brachial index; Cardio–ankle vascular index; Endothelial function; Flow-mediated dilation; Imeglimin; Systolic time interval.

Publication types

Letter